Triclosan, carbamazepine and caffeine removal by activated sludge system focusing on membrane bioreactor
dc.contributor.author
dc.date.accessioned
2018-07-27T06:45:23Z
dc.date.available
2018-07-27T06:45:23Z
dc.date.issued
2018-06-21
dc.identifier.issn
0957-5820
dc.identifier.uri
dc.description.abstract
Alternative processes need to be designed for the treatment of industrial effluents containing pharmaceutical and personal care products to improve their quality, permit the reuse of water for industrial applications and meet the standards set by environmental regulations prior to discharge. This type of effluent is a major source of water pollution since conventional activated sludge-based treatments are not effective in removing micropollutants.
Carbamazepine, caffeine and triclosan are important trace contaminants commonly found in wastewater treatment plants, and were selected as target compounds to be treated in a cyclic anoxic/aerobic membrane bioreactor. This study aims to evaluate the biomass’ characteristics and activity, and its influence over membrane fouling when treating the aforementioned compounds. Caffeine is known to be partially biodegraded whereas triclosan can inhibit microorganism’s activity. In order to evaluate this effect, complimentary batch experiments were set up to determine whether triclosan might inhibit nitrification.
Low ammonia removal efficiencies were observed in both experimental systems, therefore suggesting that nitrification was being inhibited probably due to the presence of triclosan. The ultrafiltration membrane bioreactor process demonstrated to be an efficient and appropriate technology for chemical oxygen demand removal, achieving an average of 97%, for caffeine reaching up to 93.7 ± 9.7 removal efficiencies, and 89.7 ± 8.3% for triclosan. For carbamazepine the removal was lower (36.2 ± 6.8%) due to its recalcitrance. Furthermore, biomass filterability indicators displayed high sludge deterioration increasing substantially the fouling
dc.description.sponsorship
Hèctor Monclús acknowledges support from the Spanish Ministry of Economy, Industry and Competitiveness for co-funding the postdoctoral grant (IJCI-2015-23159) and People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement n° 600388 (TECNIOspring program), and the Agency for Business Competitiveness of Government of Catalonia (ACCIÓ) for funding this study (TECSPR 14-2-0021). This study was financed by the Spanish Ministry of Economy and Competitiveness (MINECO) through the project CGL2013-48802-C3-2-R. LEQUIA has been recognized as consolidated research group by the Catalan Government (2017-SGR-1552)
dc.format.mimetype
application/pdf
dc.language.iso
eng
dc.publisher
Elsevier
dc.relation
info:eu-repo/grantAgreement/MINECO//CGL2013-48802-C3-2-R/ES/EVALUACION DE LOS EFECTOS DEL USO DE AGUAS NO CONVENCIONALES EN LA ZONA NO SATURADA Y SATURADA. ENFOQUE MULTIDISCIPLINAR/
dc.relation.isformatof
Reproducció digital del document publicat a: https://doi.org/10.1016/j.psep.2018.06.019
dc.relation.ispartof
© Process Safety and Environmental Protection, 2018, vol. 118, p.1-9
dc.relation.ispartofseries
Articles publicats (D-Q)
dc.rights
Tots els drets reservats
dc.subject
dc.title
Triclosan, carbamazepine and caffeine removal by activated sludge system focusing on membrane bioreactor
dc.type
info:eu-repo/semantics/article
dc.rights.accessRights
info:eu-repo/semantics/embargoedAccess
dc.date.embargoEndDate
info:eu-repo/date/embargoEnd/2026-01-01
dc.type.version
info:eu-repo/semantics/publishedVersion
dc.identifier.doi
dc.identifier.idgrec
028695
dc.contributor.funder
dc.type.peerreviewed
peer-reviewed
dc.relation.ProjectAcronym